During neurogenesis, complex networks of genes act sequentially to control neuronal differentiation. In the neural tube, the expression of Pax6, a paired-box-containing gene, just precedes the appearance of the first post-mitotic neurons. So far, its only reported function in the spinal cord is in specifying subsets of neurons. Here we address its possible function in controlling the balance between proliferation and commitment of neural progenitors. We report that increasing Pax6 level is sufficient to push neural progenitors toward cell cycle exit and neuronal commitment via Neurogenin 2 (Ngn2) upregulation. However, neuronal precursors maintaining Pax6 On fail to perform neuronal differentiation. Conversely, turning off Pax6 function in these precursors is sufficient to provoke premature differentiation and the number of differentiated neurons depends of the amount of Pax6 protein. Moreover, we found that Pax6 expression involves negative feedback regulation by Ngn2 and this repression is critical for the proneural activity of Ngn2. We present a model in which the level of Pax6 activity first conditions the moment when a given progenitor will leave the cell cycle and second, the moment when a selected neuronal precursor will irreversibly differentiate.
Introduction
The vertebrate central nervous system is composed of a multitude of functionally specialized cells that are derived from a common pool of neural precursors. During spinal cord maturation, neural progenitors go through several steps of differentiation. At early stages, all progenitors proliferate and are located in the ventricular zone (VZ) of the neural tube. Then, through intrinsic and environmental signals, some of them are selected to leave the cell cycle and start to express young neuronal characters. These selected precursors exit laterally from the ventricular zone to accumulate in the mantle layer (ML) where they fully differentiate as mature neurons. Each neural cell will follow this developmental scheme at a time depending on its position along the antero-posterior (A-P) and dorso-ventral (D-V) axis.
The comprehension of the genetic control involved in this general program of neurogenesis recently made a lot of progress. The identification of proneural genes which encode for bHLH transcription factors provided a good start in understanding the molecular control of vertebrate neurogenesis. These families of genes, homologous to the achaetescute and atonal group of genes, first characterised in Drosophila, are necessary and sufficient to confer a neuronal identity to a neural progenitor (Bertrand et al., 2002) . In vivo, the ectopic expression of members of ato and Neurogenin families in the surface ectoderm of Xenopus and zebrafish embryos or in the neural tube of chick embryos drives progenitor cells out of the cell cycle and promotes neuronal differentiation (Blader et al., 1997; Kim et al., 1997; Lee et al., 1995; Ma et al., 1996; Mizuguchi et al., 2001) . At the opposite, loss of function of proneural genes leads to the reduction of at least some subsets of neurons (Fode et al., 2000; Kim et al., 2001; Ma et al., 1998) .
Linked to the proneural activity, lateral inhibition is taking place to regulate the proportion of dividing progenitors that leave the cell cycle and differentiate at each given position (Louvi and Artavanis-Tsakonas, 2006) . Expression of a proneural gene in a cell leads to the upregulation of Notch ligands (as Delta, Serrate) that interact with the Notch receptor present at the surface of the neighbouring cells thereby activating in the latter the expression of neurogenesis inhibitors like some HES transcription factors de la Pompa et al., 1997) . Hence, proneural genes restrict their own activity to single cells and the balance between this proneural activity and Notch activity will determine the time when a given progenitor exits the cell cycle and moves into a differentiation program (Louvi and Artavanis-Tsakonas, 2006) . Positive feedback mechanisms will then contribute to stabilize the commitment of progenitors to differentiation (Bertrand et al., 2002) . Finally, bHLH genes of the NeuroD family will be transiently expressed in post-mitotic differentiating neurons preceding the appearance of pan-neuronal markers such as βTubulin, HuC/D or NeuN (Diez del Corral and Storey, 2001) .
One important transcription factor involved at many different levels of specification and differentiation is the Paired box gene Pax6. In the spinal cord, the initial analysis of the Small eye (sey) mice, which carry a natural mutation in the Pax6 gene (Hill et al., 1991) , revealed that Pax6 plays a role in the specification of certain subtypes of ventral neurons. Indeed, in the Pax6 Sey/Sey mice, the neural tube patterning is altered (Ericson et al., 1997b) and for example, the dorsal limit of Nkx2.2, which is controlled by Pax6, is expanded dorsally (Briscoe et al., 2000; Ericson et al., 1997b; Lei et al., 2006) . Following these patterning changes, the generation of V1 and V2 subtypes of ventral interneurons is impaired and the specification of subsets of motoneurons (MNs) is altered (Ericson et al., 1997b) . Moreover, in progenitors for ventral motor neurons, the activity of Pax6 is critical for the expression of the bHLH protein Olig2 that plays a pivotal role in motoneuron differentiation and specification Mizuguchi et al., 2001; Novitch et al., 2001) . In the chick, Pax6 is detected from the 4-somite stage in the spinal cord primordium and extends caudally in a head to tail sequence accompanying neural tube elongation and maturation (Goulding et al., 1993; Li and Noll, 1994) . At the onset of its expression Pax6 transcripts are found in all neural progenitors in the dorso-ventral axis, only excluded from the roof plate and the floor plate (Goulding et al., 1993; Ericson et al., 1997b) . Its domain of expression is then progressively restricted to the intermediary zone following negative influences by BMP and Shh molecules secreted from the dorsal and ventral parts of the neural tube, respectively (Pituello, 1997) . Pax6 activation is controlled by the signalling pathways that regulate neuronal differentiation. Hence, Pax6 is absent from the caudal neural plate, containing the stem cell zone (Akai et al., 2005; Mathis et al., 2001) being repressed there by FGF signalling which keeps neural progenitors in the cell cycle and prevents precocious neuronal differentiation (Bertrand et al., 2000; Diez del Corral et al., 2003; Lobjois et al., 2004; Pituello et al., 1999) . Then, Pax6 is activated in the closing neural tube by retinoic acid signalling concomitantly with the activation of neuronal determinants (Diez del Corral et al., 2003; Novitch et al., 2003) .
Recent data suggest that Pax6 could be involved in neuronal commitment in the spinal cord: Indeed, Pax6 positively controls some aspects of the proneural gene Ngn2 expression in the mouse spinal cord (Scardigli et al., 2001) and this regulation is direct and dependent to the level of Pax6 protein (Scardigli et al., 2003) . Furthermore, analysis of Pax6 sey/sey mice shows that Pax6 delays the time of emergence of some motoneurons (Sun et al., 1998) . As Pax6 is initially activated in most neural progenitors at a time just preceding neuronal differentiation but is in the same time restricted to proliferating progenitors, we decided to investigate Pax6 function in the time frame of early neuronal differentiation in details. By gain and loss of function experiments in the chick neural tube, we found that the threshold of Pax6 protein is critical for cell cycle exit and neuronal commitment. Once neural progenitors are committed to a neuronal program, Pax6 protein has to be turned off to allow neuronal differentiation. Moreover, loss of function experiments in chick or mouse embryos reveal that the absence of Pax6 leads to precocious neuronal differentiation. Finally, we show that the downregulation of Pax6 expression can be controlled by high levels of Ngn2. Our conclusions support a role for Pax6 in maintaining neuronal precursors in a "pre-differentiation" state by counteracting the proneural activity of Ngn2.
Materials and methods

Embryos
Fertile hen's eggs obtained from a local supplier were incubated at 38°C in a humidified incubator for appropriate periods to yield embryos of stage 9-11 (Hamburger, 1992) .
Mouse embryos in which Pax6 is replaced by β-Galactosidase (Pax6-LacZ) were obtained from P. Gruss (St-Onge et al., 1997) and propagated by heterozygous mating. E8.5 to 10.5 dpc embryos were used for the analyses and were genotyped by PCR performed on the yolk sac. The midday of the vaginal plug was designated as 0.5 day of development. The following experimental procedures were done in agreement with the French regulation concerning animal experimentation.
Electroporation of DNA
The different DNA constructs were electroporated on the left side of the neural tube of stage HH10 chick embryos as described in (Itasaki et al., 1999) . The Pax6 constructs are derived from Dr Nakamura (Matsunaga et al., 2000) ; Pax6, Pax6 VP16 and Pax6 EnR cDNA were cut from pMiw plasmid and recloned in the pCIG plasmid (Megason and McMahon, 2002) . Pax6 was also cloned in the mammalian vector pECE (Ellis et al., 1986) with or without an IRES-GFP. Control experiments have been performed by electroporation of the pCIG vector alone. Pax3 was cloned in the PcS2 vector. The Ngn2-Flag version of chick Ngn2 is a gift from P. Charnay (Garcia-Dominguez et al., 2003) ; XNotch ICD, XDelta and XDeltaSTU from Chitnis et al. (1995) ; Nkx2.2 from D. Rovitch (Sun et al., 2001) .
In situ hybridisation and immunohistochemistry
In situ hybridisation was performed as described (Bel-Vialar et al., 2002) . Riboprobes have been synthesised from isolated specific PCR fragments to avoid any corresponding plasmid regions in the probes and suppress regions of putative cross reactivity between the probes or probes and transgenes (sequences of primers used are available on request). Pax6 probe is described in Pituello et al. (1995) , NeuroM plasmid is a gift from T. Roztocil (Roztocil et al., 1997) , C-Delta-1 and Sox2 a gift from D. Henrique , cNgn2 a gift from J. M. Matter (Skowronska-Krawczyk et al., 2004) , mNgn2 from F. Guillemot (Gradwohl et al., 1996) . Immunohistochemistry was performed as described (Lobjois et al., 2004) . Embryos were fixed 2 h in 4% paraformaldehyde at 4°C. Stage HH10 embryos and E8.5-9.5 dpc staining were performed on whole mount. For older embryos the spinal cord was transversally sectioned in 45 μm slices with a vibratome (Leica VT1000S) before immunohistochemistry. Detailed references of used antibodies are available as a Supplementary material. Analyses were done with a Leica TCS SP-2 spectral confocal and a multiphoton microscope. Analysis of apoptosis was performed using an In Situ Cell Death detection kit (Roche).
Cell proliferation analysis
For proliferation analysis, 20 μl of bromodeoxyuridine (BrdU, 10 μg/μl) are deposed on the chorioallantoic membrane of electroporated embryos and incubated 30 min before fixation. Cells in mitosis were visualized using an anti phospho-histone H3 (H3P). The percentages of transgenic neural precursor cells in S-and M-phase were determined by counting the number of total GFP nuclei per section and the number of nuclei expressing both GFP and BrdU or both GFP and H3P on optic confocal sections of 5 μm thickness.
Quantification analysis in the chick experiments
The data represent mean ± S.E.M. of cell counts and correspond to the analysis of 3 to 5 sections of at least 6 embryos processed in 3 to 5 independent experiments for each conditions (more than 2000 cells counted for each condition).
Results
Increasing Pax6 levels induces Ngn2 but is not sufficient to initiate neuronal differentiation
It was previously established that Pax6 upregulates Ngn2 levels in the neural tube, suggesting that Pax6 may control neuronal commitment (Scardigli et al., 2003) . The activation of Ngn2 in neural progenitors precedes the final mitosis and is followed closely by an increased expression of cDelta-1 and NeuroM Murciano et al., 2002; Roztocil et al., 1997) . Pax6 is expressed in proliferating progenitors and its expression is extinguished as neuronal precursors differentiate ( Supplementary Fig. 9 ). In the Pax6 expression domain, we consistently observed that the level of Pax6 protein is not identical in all cells ( Supplementary Fig.  9 ) raising the possibility that these differences may be critical for neuronal commitment. We thus cloned Pax6 in two different vectors allowing to express either high level (Pax6-IRES-nuclearGFP construct in pCIG (Megason and McMahon, 2002) referred here as Pax6 high ) or low level of Pax6 (Pax6 in the pECE vector referred as Pax6 low (Ellis et al., 1986; Stamataki et al., 2005) ; see levels of transgenes in Supplementary Fig. 9 ). Transgenic embryos were checked for Ngn2, cDelta-1 and NeuroM expression 6 h following electroporation. As anticipated, Ngn2 was quickly upregulated in the electroporated zone with Pax6 high (Figs. 1A-D; n = 8/8) but this induction was clearly less efficient when Pax6 low was used as only 2/10 embryos upregulated Ngn2 (Figs. 1I-K). However, we could not detect any upregulation of either cDelta-1 (Figs. 1E, F; n = 0/5) or NeuroM expression (Figs. 1G, H; n = 0/5) suggesting that Pax6 high cells did not progress in neurogenesis in response to Ngn2 upregulation. To ascertain that cells in the caudal neural groove were competent to engage in neuronal differentiation, we transfected a Ngn2-flag construct (Garcia-Dominguez et al., 2003) and checked 5 h after for cDelta-1 and NeuroM expression. Both cDelta-1 and NeuroM were strongly induced by Ngn2 electroporation (Figs. 1L, M; n = 6/6 and Figs. 1N, O; n = 3/3). These results indicate that the amount of Pax6 protein is critical to induce neuronal commitment. However, caudal neural precursors fail to initiate neuronal differentiation when maintaining Pax6 expression, even in conditions of high levels of Ngn2.
Neural cells maintaining Pax6 expression never become neuron
In order to check if neuronal differentiation was blocked or only delayed following Pax6 misexpression, we looked at neuronal markers 24 h or 40 h following Pax6 high or Pax6 low electroporation. After 24 h, transgenic neural precursors did not succeed in inducing cDelta-1 and NeuroM and the expression of these two genes is downregulated following Pax6 high electroporation ( Supplementary Fig. 10 ). Olig2 was similarly decreased in these experimental conditions ( Supplementary  Fig. 10 ). Moreover, Ngn2 that was upregulated earlier was not maintained in transfected cells ( Supplementary Fig. 10 ). Consequently, the expression of the neuronal protein βTubulin was strongly reduced when using Pax6 high ( Figs Supplementary Fig. 10 ). This phenotype is cell autonomous as with both constructs, none of the Pax6 transgenic cells did express βTubulin (Figs. 2A, D, E) as checked by quantifying the number of transgenic βTubulin cells (Fig.  2G ). The same results were obtained by expressing an activator form of Pax6 made of the paired domain and homeodomain of Pax6 fused to the transactivation domain of VP16, indicating that Pax6 acts as a transcriptional activator in this context (not shown). After 40 h, in embryos transfected with Pax6 high , we observed some GFP + Pax6 + cells positioned in the mantle region among differentiating neurons, indicating that Pax6 high cells can migrate out of the ventricular zone (Figs. 2L, N; n = 10/10). Although these cells located in the differentiation zone do not retain the expression of the young neural protein Sox2, (Figs. 2U, V) they do not switch on the pan neuronal HuC/D (see patches of GFP + HuC/D − cells in the middle of GFP − HuC/D + cells in Fig. 2N ). The use of a nuclear neuronal marker, NeuN, to quantify the number of mature neurons within the transgenic population (Figs. 2O, P), confirms that even after a longer term, none of the Pax6 high cells differentiated as neuron ( Fig. 2H ). Using Pax6 low , the size of HuC/D domain was also reduced compared to the control side. However, while many GFP + Pax6 off cells (GFP produced by the co-injected vector peGFP) did migrate out of the ventricular zone and expressed HuC/D (Figs. 2Q-T) we could not detect any Pax6 low cells in the differentiation field. This suggests that the Pax6 low transgenic cells did not migrate out of the ventricular zone. Importantly, however, none of the Pax6 low transgenic cells expressed HuC/D after 40 h of incubation (Figs. 2Q-T) indicating that neuronal differentiation is also impaired when maintaining low levels of Pax6 protein in neural precursors. All together, these observations were indicative of a persistent block of neuronal differentiation in neural precursors maintaining Pax6 On .
High levels of Pax6 affect proliferation of neural progenitors
The neuronal block we observed was accompanied by a severe reduction of the neural tube size following injection with Pax6 high (Figs. 2B, L). We checked the apoptotic status of electroporated cells by TUNEL analysis and we could not detect differences in the number of dying cells between the electroporated and the non electroporated sides ( Supplementary  Fig. 11 ). As we could not detect any increase in apoptosis, the narrowing of the neural tube was suggestive of a proliferation defect and prompted us to analyse the proliferation and mitotic indexes in the transgenic population by BrdU incorporation and histone 3-phosphorylated (H3P) staining. Following Pax6 high injection, we observed a global reduction of H3P and BrdU staining whereas the injection of Pax6 low did not affect proliferation ( Supplementary Fig. 11 ). We quantified in each experimental conditions the number of BrdU-or H3P-positive cells among the transfected population (Figs. 2I, J). The number of cells in S phase was strongly reduced following Pax6 high injection ( Fig. 2I ; n = 9), with only 8.5% of the transfected cells incorporating BrdU, while 30% of Pax6 low and 27% of control transfected cells incorporate BrdU (n = 5 and n = 9). Similarly, we measured a 3-fold decrease in the mitotic index of Pax6 high cells ( Fig. 2J ; n = 8) indicating that cell cycle progression was globally affected. Hence, while high levels of Pax6 affect the proliferation of neural progenitors low levels of Pax6 do not. This suggests that increasing Pax6 levels is a mean to direct selected neuronal precursors toward cell cycle exit by way of Ngn2 activation.
Reversal of the neuronal block in transgenic cells that are losing the Pax6 protein
Our results so far show that following Pax6-mediated Ngn2 induction, neuronal differentiation is blocked in neuronal progenitors maintaining Pax6 On . If maintenance of Pax6 is the only reason for which neuronal differentiation cannot occur, switching it off should be sufficient to reverse the neuronal block. We therefore asked what would happen in a transgenic cell maintaining Pax6 On during 24 to 48 h and then turning off Pax6 protein. To answer this question, we took advantage of the fact that electroporation is a transient mean of expression. The GFP protein being more stable than the Pax6 protein, we should find a time window when some transgenic cells have extinguished Pax6 protein but retained GFP expression. We constructed a pECEPax6 vector now linked to an IRES-GFP (Pax6 low -GFP) to ensure that the GFP cells we are looking had expressed the Pax6 protein earlier. As already seen with the Pax6 low construct, cells expressing the Pax6 low -GFP construct do not differentiate as neuron when analysed 24 h after electroporation (Figs. 3A-F). After 50 h of incubation, we detect many GFP + transgenic cells that have lost the expression of Pax6 protein and these cells do now express the βTubulin (Figs. 3G-L). We observed a good correlation between the GFP + PAX6 off status and the expression of βTubulin as transgenic GFP + cells, in which Pax6 protein expression persists, remain βTubulin-negative. Hence, neuronal precursors that are artificially blocked in a non-differentiated state for a long period of time are able to reverse their phenotype and to differentiate into neuron as Pax6 transgenic protein goes down. This strongly suggests that Pax6 acts to maintain selected neuronal progenitors in an immature "pre-differentiated" state.
Turning off Pax6 in the ventricular zone leads to premature neuronal differentiation If Pax6 works to keep selected neuronal precursors in a non differentiated state, removing Pax6 function prematurely in neuronal precursors should lead to a precocious neuronal differentiation. To test that idea further, we used a dominant negative form of Pax6, construct linking the HD and paired domain of Pax6 to the repressor domain of the chick engrailed gene (Pax6 EnR ) (Matsunaga et al., 2000) . We chose to overexpress Pax6 EnR in the neural tube at HH10. At this stage, many neural precursors located in the ventricular zone already express Pax6 and Ngn2. Thus, the expression of Pax6 EnR should repress Pax6 targets in proliferating uncommitted progenitors as well as in post-mitotic neuronal precursors. We first examined the embryos 24 h after electroporation and observed an accumulation of the βTubulin (Figs. 4A-C; n = 12/12) and HuC/D in the ventricular zone (Figs. 4D-F; n = 6/6), when βTubulinand HuC/D-positive cells are only detected lateral to this zone in a wild type situation or following the electroporation of the GFP-tagged control vector (not shown; n = 8). When quantified, the number of GFP + βTubulin + cells was increased from 5% with a control vector to 16.5% in the Pax6 EnR population (Fig. 4Q ). Moreover, we detected Pax6 EnR GFP + cells co-expressing p27 (marker of G0 phase) in the ventricular zone (Figs. 4G-J; n = 3), suggesting that these cells passed through the G0 phase of the cell cycle prematurely. At the same time, the expression of Ngn2 is strongly reduced, probably reflecting a reduction of the neuronal precursors pool and consequently, the number of cDelta cells is also slightly reduced ( Supplementary Fig. 12 ). The presence of ectopic neurons in the ventricular zone could be the consequence of a migration defect and/or could reflect a premature neuronal differentiation due to the repression of Pax6 targets in selected precursors. To distinguish between these two possibilities, we analysed the position of GFP cells 48 h after electroporation. At this stage, cells transfected with the GFPtagged control vector were detected throughout both the ventricular zone and the mantle layer ( Fig. 4K) whereas in a subset of Pax6 EnR -transfected embryos, most GFP + cells had migrated out of the ventricular zone ( Fig. 4L ). We then measured the proliferative index of transfected cells, assuming that a migration defect would not affect this parameter whereas a premature differentiation would reduce the size of the pool of proliferating progenitors. Following electroporation with the Pax6 EnR construct, the mitotic index was not significantly changed (Figs. 4O, P, Q) but we observed a significant reduction of the pool of cells in S phase (Figs. 4M, N, Q; n = 7; 19% of Pax6 EnR cells are BrdU + ) as expected if neural progenitors are pushed prematurely out of the cell cycle to differentiation. Hence, the preferential location of Pax6 EnR in the mantle layer reflects a premature exit of the cell cycle and differentiation. The co-expression of Pax6 with Pax6 EnR abolished the accumulation of βTubulin induced by Pax6 EnR alone while co-expression with Pax3 could not ( Supplementary Fig. 13 ), confirming the specificity of the phenotype (Pax3 itself having a weak or no effect on neuronal differentiation, Supplementary Fig. 13 ). On the contrary, the co-injection of Nkx2.2 reverses the precocious neuronal differentiation induced by Pax6 EnR but Nkx2.2 also blocks neuronal differentiation when injected alone, suggesting that it is acting itself at another level of neuronal differentiation (not shown). In conclusion, active repression of Pax6 targets is sufficient to induce neuronal differentiation.
Analysis of Pax6 mutant mice reveals a dose-dependant role for Pax6 in early neuronal differentiation
All together our previous data suggest that Pax6 is able to act on the onset of neurogenesis by increasing Ngn2 levels but also to control the timing of neuronal differentiation by keeping neuronal precursors in an undifferentiated state. We thus wondered what would happen in a context where Pax6 protein is totally absent. Analysis of Pax6 mutant mice already revealed that Pax6 is involved in some aspect of neuronal specification in the spinal cord (Ericson et al., 1997b) . However, these studies have been done on 10 dpc embryos, i.e. too late to identify a putative function of Pax6 at the onset of neurogenesis. Therefore, we decided to perform a careful analysis of the Pax6-LacZ mutant mice (St-Onge et al., 1997) . We first confirmed that the staining of Islet-1 (motoneurons marker) was reduced at 9.5 and 10.5 dpc in this Pax6-LacZ mouse strain, as described for the Pax6 sey mutant (not shown). We then concentrated on early stages (between 8.5 and 9.5 dpc) focusing on neuronal commitment (Ngn2 expression) and neuronal differentiation (βTubulin expression).
We first compared the Ngn2 transcripts at 8.5 dpc and saw that the overall pattern of Ngn2 expression is the same in all the littermates from Pax6-LacZ heterozygous intercrosses (Figs. 5A-C). In particular, the rostro-caudal extension of Ngn2 is not altered suggesting that Pax6 is dispensable for initiating Ngn2 transcription (Figs. 5A-C, F, I, L; Leroux, personal communication). However, when analysed in detail, we observed a clear reduction of the transcript in the posterior hindbrain (Figs. 5D, G, J) and in the dorsal aspect of the prospective cervical spinal cord (Figs. 5E, H, K) while the caudal region is not significantly affected (Figs. 5F, I, L) . At Fig. 3 . Transgenic cells losing Pax6 expression perform neuronal differentiation. Stage HH10 chick embryos were electroporated with the Pax6 low -GFP construct. 24 h following electroporation, most of the transgenic cells co-express the GFP and the Pax6 protein (A-F) and none of these cells do express the βTubulin (arrowheads). When the embryos are incubated longer, some transgenic cells are losing the expression of Pax6 whereas still expressing the GFP protein which is more stable (G-L). These cells are no more blocked in an immature state and now express the βTubulin protein (see the group of GFP + PAX6 − βTub + cells surrounded with dash points in panels J, K, L). Note that transgenic cells that still retain Pax6 expression do not turn on βTubulin (arrows in panels J, K, L). 9.5 dpc, we still observed a downregulation of Ngn2 expression (Figs. 5M-R) which now extends to the brachial region (Figs. 5Q-R) but the domains of expression remain almost unchanged (Figs. 5M, R) . These observations suggest that even if Pax6 regulates some aspect of Ngn2 transcription, at these early stages, a large part of Ngn2 expression seems independent of Pax6. Therefore, if our prediction is true, having at 8.5 dpc in the absence of Pax6 an almost normal Ngn2 level in the ventral part of the neural tube should give rise to a precocious neuronal differentiation. We thus analysed neuronal differentiation by looking at βTubulin expression at 8.5 dpc, which corresponds to the stage when the first differentiated neurons appear in the spinal cord. To perform an accurate quantitative analysis, we compared the number of βTubulin cells in littermate embryos displaying the same number of somites (Figs. 5S-V), the number of differentiating neurons growing rapidly at that age. At 8.5 dpc we detected a clear advance in neuronal differentiation in the absence of Pax6. Indeed, βTubulin cells are already detectable in Pax6 −/− embryos from 7-somite stage whereas we could not detect any βTubulin cells before 8-somite stage in the wild type or heterozygous littermates (Fig. 5V) . At the 10-somite stage, we still have more neurons that are produced in the Pax6 homozygous embryos if compared to the wild type and heterozygous embryos (Figs. 5S-V). Moreover, we detected a clear difference in the number of βTubulin-expressing cells between heterozygous and wild type littermates revealing the importance of Pax6 levels for this aspect of its function. When we looked at 9.5 dpc, we could not detect any obvious change in the number of βTubulin cells between heterozygous or homozygous (not shown) but the analysis is rendered difficult due to the huge amount of differentiated cells at this stage. We concluded that at 9.5 dpc, either the phenotype is compensated by some other mechanisms or the decrease of Ngn2 expression leads to a reduction of the number of selected neuronal precursors counterbalancing the premature neuronal differentiation due to Pax6 off . All together these analyses in young mouse embryos confirm the data we obtained in the chick embryo showing that Pax6 off absence leads to precocious neuronal differentiation. This also brings light to the fact that the function of Pax6 is dosage-dependant, as for its other functions in eye development (Hill et al., 1991; Schedl et al., 1996) .
High levels of Ngn2 downregulate in feedback Pax6 expression
Having shown that downregulation of Pax6 activity in cells following Ngn2 activation is a prerequisite to neuronal differentiation, the next question was how is Pax6 expression downregulated in committed precursors? One possibility was that it could be part of the proneural activity of Ngn2. Moreover, Notch signalling could be directly involved as it is linked to proneural activity and has been shown to control Pax6 expression in other systems (Kumar and Moses, 2001; Onuma et al., 2002) . We therefore expressed Ngn2 and different components of the Notch signalling pathway known to interfere with lateral inhibition . XNotch ICD and XDelta maintain neural cells in an undifferentiated state; XNotch ICD being an activated form of Notch and XDelta because it overstimulates the Notch receptor. XDelta Stu is a truncated form of XDelta unable to contact the Notch receptor, provoking massive neuronal differentiation. We electroporated these different constructs in the neural groove of HH10 embryos and checked 6 h after for Pax6 expression, considering that a direct downregulation should be a rapid event. We detected a clear repression of Pax6 transcripts in cells electroporated with the Ngn2-Flag construct (Figs. 6E-J; n = 4/4) whereas we could not see any significant change following XNotch ICD injection (Figs. 6A, B ; n = 8/10; 2/10 showed a weak repression), XDelta injection (Figs. 6C, D; n = 0/9) or XDelta Stu injection (not shown, n = 0/7). After 24 h following Ngn2 overexpression, Pax6 endogenous expression was still strongly reduced (Figs. 6K, M) and this was correlated with a premature expression of βTubulin (Figs. 6K, L) . These results indicate that high levels of Ngn2 are sufficient to extinguish Pax6 expression in committed neuronal precursors. This effect could be indirect and go through NeuroM which is rapidly upregulated upon Ngn2 electroporation (see Fig. 1 ). Moreover, the fact that Ngn2 but not XDelta stu rapidly represses Pax6 expression suggests that turning off Pax6 function is a rapid and critical event required to perform neuronal differentiation following Ngn2 induction and is not an indirect consequence of lateral inhibition.
Pax6 counteracts Ngn2 proneural activity
The fact that Pax6 protein repression by Ngn2 is closely linked to the induction of neuronal differentiation suggested that turning off Pax6 function is required for the proneural activity of Ngn2. We therefore tested the possibility that high levels of Pax6 could block Ngn2 ability to induce neuronal differentiation. The co-expression of Pax6 and Ngn2 leads to a reduction of βTubulin expression (Figs. 7G-I) instead of its accumulation when misexpressing Ngn2 alone (Figs. 6K, L and 7A-C) . Hence, the resulting phenotype mimics the one of injecting Pax6 alone (Figs. 7D-F) . We therefore concluded that the proneural activity of Ngn2 is counteracted by high levels of Pax6 expression.
Discussion
In this study, by using both chick and mouse to perform either gain or loss of function experiments in early embryos, we reveal a new dosage-dependant function of Pax6 in controlling the timing of neuronal differentiation. We show that, if Pax6 function is dispensable for Ngn2 expression, it contributes to raising the level of that proneural factor in a dose-dependant manner, thus participating in the commitment of neural progenitors to a neuronal fate. However, the presence of Pax6 at any level in committed neuronal precursor precludes their differentiation, suggesting that switching off Pax6 is a gate for timing neuronal differentiation. We also demonstrate that Ngn2 is able to downregulate Pax6 in feedback and this may be an important part of its proneural activity. All together, our data show that the generation of neurons from neural progenitors involves fine cross regulations between Pax6 and Ngn2 proteins.
A Pax6 protein threshold is critical for the activation of Ngn2 and proliferative behavior of neural progenitors
We have investigated the role of Pax6 in neuronal commitment considering that the amount of Pax6 protein could be of capital importance. We show that Pax6 is able to upregulate Ngn2 in neural progenitors and this upregulation is dose-dependent. Indeed, in the chick the upregulation of Ngn2 with Pax6 low was poorly efficient whereas this upregulation was observed in all embryos electroporated with Pax6 high . This reflects the need of a certain threshold of Pax6 to induce Ngn2 and with the pECE vector such critical threshold is more randomly reached than with the pCIG vector, explaining the variability of the phenotype. These experiments done in the chick and in another published data (Scardigli et al., 2003) clearly show that Pax6 is able to regulate several aspects of Ngn2 expression at early stages. However, we only observed a moderate downregulation of Ngn2 transcripts in Pax6 mutant mice. This could be due to redundant activity performed by other genes in the absence of Pax6. Alternatively, Pax6 function may be dispensable for Ngn2 activation and be required only to reinforce Ngn2 levels and thus neuronal selection. In this case, maintaining high levels of Ngn2 expression could be critical at some stage to allow a sufficient number of neural progenitors to commit toward a neuronal fate (Fig. 8) . In parallel with this Ngn2 upregulation, Pax6 high cells show a strong reduction of cell proliferation. However, Pax6 + neural cells do not express p27 at the stages we studied ( Supplementary Fig. 9 ) and transgenic Pax6 high cells do not turn on p27 (not shown) suggesting that they did not exit the cell cycle. A decrease in proliferation has also been reported following injection of high levels of Pax6 in glioblastoma cells and in that context, the decrease is associated with a block in G1 phase of the cell cycle (Zhou et al., 2005) . This opens the possibility that in our experimental context, even if they engaged toward cell cycle exit, Pax6 high cells may not have succeeded to reach the G0 phase and could have been blocked instead in some phase of the cell cycle.
Switching off Pax6 function allows to progress in the differentiation program
Our loss of function experiments done in the chick and mouse embryos lead us to propose that in the embryonic spinal cord, "Pax6 off " is a gate for timing neuronal differentiation (Fig. 8) . In Pax6 loss of function mutant mice, different phenotypes linked to the timing of neuronal differentiation have been observed which depend of the cellular context. In the eye, numerous neurons differentiate precociously in the Fig. 7 . Pax6 counteracts the proneural activity of Ngn2. After 24 h, cells electroporated with Ngn2 accumulate high levels of βTubulin in the proliferating zone (A-C). Conversely, cells injected with Pax6 high do not express βTubulin (D-F). When Pax6 is co-injected with Ngn2, it blocks the capacity of Ngn2 to induce neuronal differentiation (G-I).
optic vesicle (Philips et al., 2005) . In the cerebral cortex, many ectopic neurons are accumulated in the ventricular zone at E19 when this zone normally contains only proliferating progenitors (Caric et al., 1997) . Moreover, a recent study showed that Pax6 acts early and autonomously in the cortex to prevent precocious differentiation and depletion of the progenitor pool (Quinn et al., 2007) . In the mutant spinal cord, most neurons are generated correctly but motoneurons and the few V1 interneurons that are formed appear at later stages than normal (Ericson et al., 1997b; Sun et al., 1998) . In the present study, we show that in the absence of Pax6, neuronal differentiation occurs prematurely in the 8.5 dpc spinal cord. This phenotype correlates well with the chick phenotype where downregulating Pax6 targets in the ventricular zone is sufficient to provoke premature neuronal differentiation. In both cases, cells in the ventricular zone express Ngn2 and thus have been committed to neuronal fate and are ready to differentiate. Then, as Pax6 is off, there is no impeachment to perform neuronal differentiation. Importantly, we already observed a significant increase of neuronal differentiation in the neural tube of heterozygous embryos if compared to wild type littermates. As we did not detect differences in the level of Ngn2 between these two littermates, one interpretation to explain the phenotype would be that the ratio between Ngn2 and Pax6 would more rapidly turn in favour of Ngn2 in the heterozygous, thus leading to a more rapid downregulation of Pax6 and to a premature neuronal differentiation. This data reveals the importance of Pax6 dosage in the process of neurogenesis while this dosage does not seem to influence neuronal specification (Ericson et al., 1997b) .
Regulating Pax6 levels in the spinal cord
Hence, our study highlights the quantitative aspect of Pax6 function in early neurogenesis stages. While low levels of Pax6 protein are compatible with the proliferation of neural progenitors, increasing Pax6 in some cells allows them to leave the cell cycle and reach a "pre-differentiation" state ( Fig.  8) . Moreover, the number of neurons that are generated in the first stages of mouse development is inversely correlated with the level of Pax6 protein. Thus, the amount of Pax6 protein may allow first to balance the number of proliferating progenitors with the number of committed precursors and then the number of differentiating neurons. This emphasis the need of a tight control of Pax6 levels in coordination with the growth and maturation of the spinal cord. Pax6 activation is under the control of the retinoic acid pathway and is able to autoactivate itself (Diez del Corral et al., 2003; Kleijan et al., 2004; Novitch et al., 2003) . This could be sufficient to reach a certain amount of Pax6 protein in some cells and predispose them to neuronal commitment. If Pax6 is totally absent from neural progenitors, neurogenesis induction occurs anyway suggesting that other mechanisms are able to compensate the lack of Pax6 for this step. Lately, Pax6 must be switched off to permit subsequent differentiation. The first level of restriction of Pax6 expression arises in the dorso-ventral axis, via the use of Shh and BMP signalling (Ericson et al., 1997a; Pituello et al., 1995; Timmer et al., 2002) . This way of decreasing Pax6 levels in some domains is a good way to progressively release neuronal precursors in coordination with their specification. In combination with extinguishing Pax6 expression, some Pax6 off domain could be kept in a "predifferentiated" state for a longer time by the activation by the same signalling pathways of other factors like Olig2 or Nkx2.2 playing redundant function. Concerning progenitors in the Pax6 domain, once they are selected, Pax6 must be extinguished by another way. We show that high levels of Ngn2 are capable to downregulate Pax6 expression in few hours. It has been reported that Pax6 transcript levels are reduced in the Ngn2 loss of function mutant mouse (Scardigli et al., 2001) . One explanation could be that different doses of Ngn2 exert different effects on Pax6 regulation by the use of numerous enhancers in Pax6 regulatory regions, displaying distinct affinities for Ngn2 protein. It is interesting to note that this is by such a concentration-dependent regulation that Pax6 is in turn regulating Ngn2 expression (Scardigli et al., 2001) . More likely, as Ngn2 repressor activity has never been demonstrated, Ngn2 repression of Pax6 transcripts could be indirect, and go through the action of a transcriptional Ngn2 target activated at high concentrations of Ngn2 or by a mean of a "CBP sequestration model" as it has been recently proposed for other repressed Ngn2 targets (Ge et al., 2006) . Finally, it appears that this downregulation of Pax6 protein is part of the proneural activity of Ngn2, as high levels of Ngn2 could not induce neuronal differentiation if Pax6 protein was maintained. According to that, we detected only few cells coexpressing Pax6 and Ngn2 proteins and the cells expressing high levels of Ngn2 protein do not express Pax6 anymore (Fig. 8B) . Similarly, the downstream Pax6 gene FABP7, which is required to maintain proliferative neuroepithelial cells (Arai et al., 2005) , displays the same patterns of correlative expression in relation with Ngn2 levels and this may contribute to the control of neuronal differentiation flow in this context.
Pax6 On is incompatible with neuronal differentiation in the spinal cord
In conditions of high levels of Pax6 overexpression, the combined effect on proliferation and neuronal differentiation leads to a severe defect of neurogenesis. Even if transfection of low levels of Pax6 gives a milder phenotype, having no impact on proliferation, Pax6 low transgenic cells remain refractory to neuronal differentiation. As discussed earlier, this construct is not efficient at inducing Ngn2 and we would not expect induction of neuronal differentiation. However, we observed the inverse, i.e., cells maintaining Pax6 low do not differentiate. We detected endogenous cells in the sub-ventricular zone coexpressing NeuroM and low levels of Pax6 (Fig. 8B ). These Pax6 low NeuroM + cells retain the expression of Ngn2 (not shown) suggesting that they are on their way of extinguishing Pax6 to differentiate and that Ngn2 can initiate the differentiation program even if Pax6 is still present (Fig. 8A ). However, overexpression of Pax6 high , while upregulating Ngn2, does not lead to the upregulation of NeuroM. These data, together with the fact that all the endogenous HuC/D-differentiated cells are Pax6 off , mean that Pax6 levels start to be lowered to reach the post-mitotic "NeuroM + " stage and is then switched off to reach the differentiated stage (Fig. 8A) . Thus, once neural cells have been restricted to a neuronal fate, Pax6 keeps them in an intermediary state, in which cells progressed toward cell cycle exit but cannot differentiate, that we termed the "predifferentiated state" (Fig. 8) . Other examples of disruption of cell differentiation following Pax6 overexpression has been reported: In the eye, high levels of Pax6 disrupt normal fiber cell differentiation and maturation (Duncan et al., 2000) . In the rat hindbrain, efficient electroporation of Pax6 at 11.5 dpc leads to the downregulation of Islet2 (Takahashi and Osumi, 2002) . Therefore, maintaining neural cells in a "pre-differentiation" phase could be a general property of Pax6 in the embryonic CNS. In contrast, in embryonic cortical precursors, astrocytes isolated from post-natal cortex or adult neural precursors of the olfactory bulb, overexpression of Pax6 does not inhibit but rather promote neuronal differentiation (Hack et al., 2005; Heins et al., 2002) . This is in accordance with Pax6 being maintained in some differentiated neurons in the brain but not in the embryonic spinal cord. However, most proliferating progenitors from the adult subventricular zone downregulate Pax6 to differentiate and only a few cells in the dopaminergic lineage retain Pax6 expression for their specification (Kohwi et al., 2005) . All together these data suggest that Pax6 acts as a neurogenic factor in all neural precursors of the adult and embryonic CNS but in the adult CNS Pax6 is also required in a subset of young neurons to maintain a specification pressure toward the dopaminergic fate. Other transcription factors like Olig2 and Ath5 have been shown to maintain neuronal precursors in a similar state Matter-Sadzinski et al., 2005) . We ourselves tested the effect of Pax3 and Nkx2.2 in this process. While Pax3 overexpression does not seem to interfere with neuronal differentiation, Nkx2.2 overexpression reduces the expression of βTubulin, suggesting that it is able on its own to regulate some aspects of neuronal differentiation. The fact that Nkx2.2 is also able to act on neuronal differentiation may explain why in the Pax6 mutant mice we do not detect a persistent premature neuronal differentiation, since Pax6 functions to control the dorsal limit of Nkx2.2 expression, which expands in its absence (Briscoe et al., 2000; Ericson et al., 1997b; Lei et al., 2006) . This control by several transcription factors expressed differentially in the ventricular zone is certainly important in coordinating neuronal differentiation with the growth of the embryo and in specifying different neuronal cell types. A pause in neurogenesis progression may be necessary for the cell to receive and interpret signals from the environment that are necessary for the specification of its identity. Several data suggest that fate specification in the developing and adult CNS occurs by progressive fate restriction from being multipotent towards further specified precursors (see Hack et al., 2004) . It has been proposed that the generation of an intermediary set of precursors restricted towards the generation of neuronal precursor is of critical importance in order to obtain a high number of differentiated neurons (Hack et al., 2004) . In this context, the challenge now will be to dissect the mechanisms by which Pax6 maintains committed neuronal precursors in this intermediary restricted fate. This could be achieved only by interfering with transcription factors involved in neuronal specification but could also go through the regulation of cell cycle parameters, as it has been suggested in others systems (Cvekl et al., 1999; Zhou et al., 2005) .
